by Legal Desire

Lawyer profile

Dan Nobil

Weil

Claim this profile

Firm: Weil
Practice: Antitrust
Office: United States
Active in the record: 2024 to 2025

Deal experience

Deal types

Fund Formation M&A Private Equity & Buyouts

Sectors

Healthcare & Life Sciences Industrials & Manufacturing Technology

Jurisdictions

Germany United Kingdom United States

Deals

7 announced deals in the record

Weil Advises PSG in $150M Investment in Uscreen 14 Feb 2025

Private Equity & Buyouts Technology Weil USD 150m Antitrust

Weil Advised PSG in Connection with Six Asset, $2B Continuation Fund 14 Feb 2025

Fund Formation Technology Weil USD 2bn Antitrust

Weil Advises H.I.G. Capital in its Take-Private Acquisition of Converge Technology Solutions 11 Feb 2025

Private Equity & Buyouts Technology Weil CAD 1.30bn Antitrust United States

Weil Advises Montagu in Acquisition of Tyber Medical and Combination with Intech and Resolve 16 Jan 2025

M&A Healthcare & Life Sciences Weil Antitrust

Weil Advises Aterian Investment Partners in Partnership with Outlook Group 7 Nov 2024

Private Equity & Buyouts Weil USD 834m Antitrust

Weil Advises Nexa Equity and Autura on Merger with Traxero 18 Oct 2024

M&A Weil Antitrust

Weil Advises Bain Capital and Pine Island in Sale of Precinmac to Centerbridge 15 Oct 2024

Private Equity & Buyouts Industrials & Manufacturing Weil Antitrust

Deal alerts PRO

Get an email when Dan Nobil is named on a newly announced deal.

Alerts come as one daily email at most.

Pro

Analytics for Dan Nobil

The paid plans add analytics for this lawyer, and for every firm and lawyer in the database:

Complete deal history, filtered by keyword, deal type, sector and year
Deals by year, sector and deal type
Frequent co-counsel and the firms most often on the other side
Repeat clients, as named in the announcements
CSV and Excel export

SEE PLANS SIGN IN

Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction